13th Aug 2007 10:45
Alliance Pharma PLC13 August 2007 For Immediate Release 13 August 2007 ALLIANCE PHARMA PLC ("Alliance" or "the Company") AIM Rule 26 Compliant Website Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announcesthat the information required by Rule 26 of the AIM Rules for Companies(February 2007) is available under the heading 'AIM Rule 26' within the'Investor Relations' section on the Company's website atwww.alliancepharma.co.uk. For further information: Alliance Pharma plc + 44 (0) 1249 466966John Dawson, Chief ExecutiveRichard Wright, Finance Directorwww.alliancepharma.co.uk Numis Securities + 44 (0) 20 7260 1000David PoutneyMichael Meade Buchanan Communications + 44 (0) 20 7466 5000Mark Court/Rebecca Skye Dietrich Notes to editors About Alliance Pharma Alliance Pharma, founded in 1996, is an AIM listed speciality pharmaceuticalcompany based in Chippenham, Wiltshire, UK. The company has a strong trackrecord of acquiring the rights to established niche brands and owns, or shares,the rights to 34 branded pharmaceutical products. Alliance Pharma's products are prescribed in the treatment of a wide range ofconditions and include brands used in periodontitis (a serious gum disease), theprevention of heart disease, in Parkinson's disease, in nutrition, in nasalinfections, in the treatment of dermatological conditions and in childbirth.Alliance Pharma's sales are mainly prescription driven. Its products aredistributed to hospitals directly and to pharmaceutical wholesalers whichservice both hospital and retail pharmacies with their prescriptionrequirements. Alliance Pharma joined the AIM market of the London Stock Exchange in December2003 and trades under the symbol APH. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Alliance Pharma